RUA Life Sciences PLC RUA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX 10.50
- Day Range
- GBX 10.13–10.80
- 52-Week Range
- GBX 8.50–58.75
- Bid/Ask
- GBX 0.00 / GBX 0.00
- Market Cap
- GBX 668.51 Mil
- Volume/Avg
- 142,262 / 627,523
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.25
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's principal activities comprise exploiting the value of its IP and know-how, medical device contract manufacturing, and development of cardiovascular devices. Its business segments are Royalty and License Income (Biomaterials), Contract Manufacture, Product Development (Vascular), and Product Innovation (Structural Heart). It derives the majority of its revenue from the Contract Manufacture segment. Geographically, it derives its major revenue from the USA and has a presence in Europe and the Rest of the world.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 48
- Website
- https://www.rualifesciences.com
Valuation
|
Metric
|
RUA
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.62 |
Price/Sales | 1.25 |
Price/Cash Flow | — |
Price/Earnings
RUA
Financial Strength
|
Metric
|
RUA
|
|---|---|
Quick Ratio | 2.40 |
Current Ratio | 2.67 |
Interest Coverage | −61.71 |
Quick Ratio
RUA
Profitability
|
Metric
|
RUA
|
|---|---|
Return on Assets (Normalized) | −31.54% |
Return on Equity (Normalized) | −38.59% |
Return on Invested Capital (Normalized) | −34.54% |
Return on Assets
RUA
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Vgqgdlg | Xjmczj | $182.4 Bil | |
SYK
| Stryker Corp | Mgsfkjtvj | Zznv | $127.2 Bil | |
MDT
| Medtronic PLC | Xzdkdkmnf | Wkjtxn | $113.7 Bil | |
BSX
| Boston Scientific Corp | Qkssnyjr | Njrxrnn | $109.6 Bil | |
EW
| Edwards Lifesciences Corp | Glftwwlty | Rjrtc | $54.3 Bil | |
DXCM
| DexCom Inc | Ynnqwfkrkn | Cmgrg | $52.2 Bil | |
PHG
| Koninklijke Philips NV ADR | Ptqnmkz | Bpjgry | $25.9 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Mxkbqcpjs | Vylf | $24.9 Bil | |
ALGN
| Align Technology Inc | Rzjmmkkc | Ldlrs | $20.6 Bil | |
SNN
| Smith & Nephew PLC ADR | Dbyhrdk | Pxnrsb | $11.4 Bil |